Evidence map›Paper›PMID 34670895›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Clinicopathological Differences between Eosinophilic Esophagitis and Asymptomatic Esophageal Eosinophilia.

Yugo Suzuki, Toshiro Iizuka, Atsuko Hosoi, Daisuke Kikuchi, Takayuki Okamura, Yorinari Ochiai, Junnosuke Hayasaka, Nobuhiro Dan, Yutaka Mitsunaga, Masami Tanaka and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Eosinophilic Esophagitis-What Do We Know So Far?Journal of clinical medicine · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Yugo SuzukiDepartment of Gastroenterology, Toranomon Hospital, Japan.
Toshiro IizukaDepartment of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hopital, Japan.
Atsuko HosoiDepartment of Pathology, Toranomon Hospital, Japan.
Daisuke KikuchiDepartment of Gastroenterology, Toranomon Hospital, Japan.
Takayuki OkamuraDepartment of Gastroenterology, Toranomon Hospital, Japan.
Yorinari OchiaiDepartment of Gastroenterology, Toranomon Hospital, Japan.
Junnosuke HayasakaDepartment of Gastroenterology, Toranomon Hospital, Japan.
Nobuhiro DanDepartment of Gastroenterology, Toranomon Hospital, Japan.
Yutaka MitsunagaDepartment of Gastroenterology, Toranomon Hospital, Japan.
Masami TanakaDepartment of Gastroenterology, Toranomon Hospital, Japan.
Hiroyuki OdagiriDepartment of Gastroenterology, Toranomon Hospital, Japan.
Kosuke NomuraDepartment of Gastroenterology, Toranomon Hospital, Japan.
Satoshi YamashitaDepartment of Gastroenterology, Toranomon Hospital, Japan.
Akira MatsuiDepartment of Gastroenterology, Toranomon Hospital, Japan.
Shu HoteyaDepartment of Gastroenterology, Toranomon Hospital, Japan.
Toranomon Hospital · JPTokyo Metropolitan Komagome Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective According to consensus guidelines, eosinophilic esophagitis (EoE) is defined as a clinicopathological entity whose symptoms and histology must always be considered together. However, endoscopic findings typical of EoE are often seen in asymptomatic esophageal eosinophilia (aEE). We aimed to clarify the clinicopathological features of aEE. Methods We retrospectively compared cases of aEE and those of symptomatic EoE. Materials We reviewed 146 patients who underwent upper gastrointestinal endoscopy and were confirmed histopathologically to have esophageal eosinophil infiltration of at least 15 eosinophils per high-power field. They were divided into the aEE group (n=75) and the EoE group (n=71). Patients' clinicopathological findings were then collected and examined. Results The EoE group experienced dysphagia (47.9%), heartburn (40.8%), food impaction (40.8%), chest pain (16.9%), and other symptoms (8.5%). There was no significant difference between the two groups with regard to age, sex, current smoking status, or alcohol consumption. The aEE group had a significantly higher body mass index (p<0.01) and significantly lower frequency of concurrent allergic diseases (p<0.01) than the EoE group. No significant differences were found between the two groups with regard to the mean peripheral blood eosinophil count, non-specific immunoglobulin E concentration, peak eosinophil infiltration in the biopsy specimens, EoE histology scoring system, phenotype and location of typical endoscopic findings of EoE, or thickness of the esophagus wall or the mucosal and submucosal layer as measured by endoscopic ultrasonography. Two patients in the aEE group who were followed up without treatment subsequently developed esophageal symptoms. Conclusion aEE and EoE may have the same clinicopathological features.

Indexed as

Deglutition DisordersEosinophilic EsophagitisBiopsyEnteritisEosinophiliaEosinophilsGastritisHumansRetrospective Studiesendoscopyendosonographyeosinophiliaeosinophilic esophagitis

Identifiers

PMID34670895
PMCPMC9152855
OpenAlexW3205503262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.